Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 4/20 | 0.44 |
| ▸ | PDE4A | P27815 | 3/20 | 0.44 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.44 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 6/20 | 0.42 |
| ▸ | ACACA | Q13085 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23969042 | 0.91 | MEN1 (0.45) | ACACBACACA | |
| SCHEMBL18909798 | 0.82 | PDE4D (0.45) | PDE4DPDE4APDE4BPDE4CACACB | |
| SCHEMBL23969218 | 0.81 | ACACB (0.41) | ACACBACACA | |
| SCHEMBL18909758 | 0.79 | PDE4D (0.50) | PDE4DPDE4APDE4BPDE4CACACB | |
| SCHEMBL18908171 | 0.79 | ACACB (0.44) | PDE4DPDE4APDE4BPDE4CACACB | |
| SCHEMBL23968963 | 0.79 | ACACB (0.42) | ACACBACACA | |
| SCHEMBL23969272 | 0.79 | ACACB (0.42) | ACACBACACA | |
| SCHEMBL21816549 | 0.78 | ACACB (0.47) | ACACBACACA | |
| SCHEMBL14945397 | 0.78 | ACACB (0.47) | ACACBACACA | |
| SCHEMBL29700513 | 0.78 | ACACB (0.47) | ACACBACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3904357-A1 | SPIRO COMPOUND AND MEDICAL USES THEREOF | The National Institutes of Pharmaceutical R&D Co., Ltd (CN) | 2021-11-03 | — | — | EP | disclosed |